Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 9781608)

1.

Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel.

Fenig E, Brenner B, Rakowsky E, Lapidoth M, Katz A, Sulkes A.

Am J Clin Oncol. 1998 Oct;21(5):498-500.

PMID:
9781608
2.
3.

Epidemiological study of classic Kaposi's sarcoma: a retrospective review of 125 cases from Northern Israel.

Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R.

J Eur Acad Dermatol Venereol. 2000 Mar;14(2):91-5.

PMID:
10972092
4.

Classic Kaposi's sarcoma in Arabs living in Israel, 1970-1993: a population-based incidence study.

Iscovich J, Boffetta P, Brennan P.

Int J Cancer. 1998 Jul 29;77(3):319-21.

PMID:
9663588
5.

Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study.

Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E.

AIDS. 1998 Oct 22;12(15):2067-72.

PMID:
9814876
6.

Classical Kaposi sarcoma: prognostic factor analysis of 248 patients.

Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, Sulkes A, Linn S.

Cancer. 2002 Nov 1;95(9):1982-7.

7.

Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.

Zidan J, Robenstein W, Abzah A, Taman S.

Isr Med Assoc J. 2001 Apr;3(4):251-3.

8.

Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.

Turk HM, Buyukberber S, Camci C, Inaloz HS, Sari I, Kirtak N, Uner A.

J Dermatol. 2002 Oct;29(10):657-60.

PMID:
12432999
9.

Classic Kaposi's sarcoma in Arabs--widening ethnic involvement.

Kumar P.

J Cancer Res Ther. 2011 Jan-Mar;7(1):92-4. doi: 10.4103/0973-1482.80456.

10.

Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews.

Brenner B, Fried G, Levitzki P, Rakowsky E, Lurie H, Idelevich E, Neuman A, Kaufman B, Sulkes J, Sulkes A.

Cancer. 2002 Apr 15;94(8):2128-33.

11.

Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent.

Huang KM, Hsu CH, Cheng JC, Lai MK, Jeng SC, Ting LL, Huang WT.

Anticancer Res. 2006 Nov-Dec;26(6C):4659-63.

12.

Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines.

Brenner B, Rakowsky E, Katz A, Gutman H, Sulkes A, Schacter J, Fenig E.

Int J Oncol. 1999 Jun;14(6):1097-102.

PMID:
10339664
13.

Classic Kaposi's sarcoma as a second primary neoplasm.

Iscovich J, Boffetta P, Winkelmann R, Brennan P.

Int J Cancer. 1999 Jan 18;80(2):178-82.

PMID:
9935196
14.

Kaposi's sarcoma: retrospective study of 67 cases with the classical form.

Friedman-Birnbaum R, Weltfriend S, Katz I.

Dermatologica. 1990;180(1):13-7.

PMID:
2307273
15.

Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?

Guttman-Yassky E, Dubnov J, Kra-Oz Z, Friedman-Birnbaum R, Silbermann M, Barchana M, Bergman R, Sarid R.

Cancer. 2006 Jan 15;106(2):413-9.

16.

Results of radiation therapy for treatment of classic Kaposi sarcoma.

Hauerstock D, Gerstein W, Vuong T.

J Cutan Med Surg. 2009 Jan-Feb;13(1):18-21.

PMID:
19298767
17.

Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998.

Guttman-Yassky E, Bar-Chana M, Yukelson A, Linn S, Friedman-Birnbaum R, Bergman R, Sarid R, Silbermann M.

Br J Cancer. 2003 Nov 3;89(9):1657-60.

18.

Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.

Kreuter A, Rasokat H, Klouche M, Esser S, Bader A, Gambichler T, Altmeyer P, Brockmeyer NH.

Cancer Invest. 2005;23(8):653-9.

PMID:
16377582
19.

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.

Di Lorenzo G, Di Trolio R, Montesarchio V, Palmieri G, Nappa P, Delfino M, De Placido S, Dezube BJ.

Cancer. 2008 Mar 1;112(5):1147-52.

20.

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C.

J Natl Cancer Inst. 2001 Feb 7;93(3):194-202.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk